GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
GEVA
Delisted
GEVA was delisted on the 22nd of June, 2015.
89 hedge funds and large institutions have $1.09B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 89 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
+89
Holders Change %
–
% of All Funds
2.91%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
89
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$597K
Net Calls
-$597K
Net Calls Change
-$597K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Bank of Montreal
Toronto,
Ontario, Canada
| $259K | +$259K | +6,181 | New |
|
77
Renaissance Technologies
New York
| $239K | +$239K | +5,701 | New |
|
78
Bessemer Group
Woodbridge,
New Jersey
| $176K | +$176K | +4,194 | New |
|
79
Barclays
London,
United Kingdom
| $95K | +$95K | +2,275 | New |
|
|
ILIM
80
Irish Life Investment Managers
Dublin,
Ireland
| $84K | +$84K | +2,000 | New |
|
|
TC
81
Travelers Companies
Saint Paul,
Minnesota
| $82K | +$82K | +1,965 | New |
|
82
Teacher Retirement System of Texas
Austin,
Texas
| $43K | +$43K | +1,020 | New |
|
|
TRCT
83
Tower Research Capital (TRC)
New York
| $41K | +$41K | +984 | New |
|
84
Citigroup
New York
| $24K | +$24K | +555 | New |
|
|
SSG
85
Summit Securities Group
New York
| $21K | +$21K | +500 | New |
|
86
BlackRock
New York
| $18K | +$18K | +438 | New |
|
|
BAM
87
Barrett Asset Management
New York
| $3K | +$3K | +79 | New |
|
88
Envestnet Asset Management
Chicago,
Illinois
| $1K | +$1K | +12 | New |
|
|
PTC
89
Private Trust Company
Cleveland,
Ohio
| $1K | +$1K | +15 | New |
|